Whitlock, Nichelle C.
White, Margaret E.
Capaldo, Brian J.
Ku, Anson T.
Agarwal, Supreet
Fang, Lei
Wilkinson, Scott
Trostel, Shana Y.
Shi, Zhen-Dan
Basuli, Falguni
Wong, Karen
Jagoda, Elaine M.
Kelly, Kathleen
Choyke, Peter L.
Sowalsky, Adam G.
Funding for this research was provided by:
National Institutes of Health (Intramural Research Program, National Cancer Institute, Intramural Research Program, National Heart Lung and Blood Institute)
Prostate Cancer Foundation (Young Investigator Award)
Congressionally Directed Medical Research Programs (W81XWH-19-1-0712, W81XWH-16-1-0433)
National Institutes of Health
Article History
Received: 18 August 2022
Accepted: 27 September 2022
First Online: 1 October 2022
Declarations
:
: The collection and analysis of tissue from patients with localized prostate cancer was approved by the Institutional Review Boards of the National Institutes of Health (protocol 15-c-0124), Beth Israel Deaconess Medical Center (protocol 2010-P-000254/0), and Dana-Farber/Harvard Cancer Center (protocols 11-250, 15-008, and 15-492). All patients provided informed consent before participating. This research was conducted in accordance with the principles of the Declaration of Helsinki. The propagation of patient-derived xenografts was approved by National Cancer Institute Animal Care and Use Committee.
: Not applicable.
: The authors declare no conflicts of interest.